Vertex Pharmaceuticals, Inc. (VRTX)
476.90
+7.63
(+1.63%)
USD |
NASDAQ |
Feb 20, 16:00
476.85
-0.05
(-0.01%)
After-Hours: 20:00
Vertex Pharmaceuticals SG&A Expense (Quarterly) : 487.00M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Moderna, Inc. | 308.00M |
| Gilead Sciences, Inc. | 1.794B |
| Eli Lilly & Co. | 3.132B |
| Merck & Co., Inc. | 2.898B |
| Pfizer Inc. | 4.162B |